|
|
|
|
Novartis receives approval in the European Union for Menveo
ovartis announced that the European Commission (EC) granted a Marketing Authorization for Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine) in all 27 European member states.Menveo is indicated for the active immunization of adolescents (from 11...
|
|
|
AARDA launches campaign on family AQ
Researchers develop noninvasive infrared scanning system to diagnose melanomasJohns Hopkins researchers have developed a noninvasive infrared scanning system to help doctors dete...LFB Biotechnologies provides new loan financing to GTC Biotherapeutics for key...
|
|
|
Chatham Street Caf To Host Fundraiser For Triangle Walk To Defeat ALS
Downtown Cary Restaurant To Host Wine Tasting Benefit On March 22 [USPRwire, Sun Mar 21 2010] Gayla Bonke, owner and chef at Chatham Street Caf & Catering (www.chathamstreetcafe.com), located at 140 E.Chatham St., has announced that the restaurant will...
|
|
|
Chatham Street Caf To Host Fundraiser For Triangle Walk To Defeat ALS
Downtown Cary Restaurant To Host Wine Tasting Benefit On March 22 [USPRwire, Sun Mar 21 2010] Gayla Bonke, owner and chef at Chatham Street Caf & Catering (www.chathamstreetcafe.com), located at 140 E.Chatham St., has announced that the restaurant will...
|
|
|
Craig Hospital continues leadership and innovation
Spinal cord and traumatic brain injuries often result in insult or injury to the cardiopulmonary system.As a consequence, a host of respiratory problems and/or diseases can ensue. At Craig Hospital, respiratory care is an integral part of the...
|
|
|
Effect of Needle Size and Type, Reuse of Needles, Insertion Speed, and Removal of Hair on Contamination of Joints with Tissue Debris and Hair after Arthrocentesis
To assess joint contamination with tissue and hair after arthrocentesis of equine fetlock joints.Experimental. Limb specimens from 8 equine cadavers. Soft tissues including the joint capsule were harvested from the dorsal aspect of the fetlock joints and...
|
|
|
Is prenatal screening for rare diseases like spinal muscular atrophy too costly?
Spinal Muscular Atrophy (SMA) is one of many serious disorders for which prenatal testing is available.SMA affects approximately 1 in 10,000 live births and is the leading genetic cause of infant mortality and the second most common autosomal recessive...
|
|
|
Amitriptyline does not block the action of ATP at human P2X4 receptor
Background and purpose: Amitriptyline is a tricyclic antidepressant that is also widely used to treat neuropathic pain in humans, but the mechanism of this anti-hyperalgesic effect is unknown.Microglia in the mouse spinal cord become activated in...
|
|
|
'Amputation is like death' in Haiti, U.S. MD learns during recent visit
When a 7.3-magnitude earthquake struck Haiti on Jan.12, leaving behind a death toll of more than 250,000, Sachita Shah, MD, of Providence, Rhode Island, was among the volunteers who packed her bags and headed to the Caribbean country to offer her services.
|
|
|
UC Denver med school launches stem-cell center
Denver's School of Medicine said Friday that its stem-cell research and treatment programs have been placed under a new regional center.CU's Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology aims to draw more private and federal...
|
|
|
TopAbstracts in Pain 03/18/2010
TopAbstracts in Pain are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.Over 2000 peer-reviewed journals are covered by...
|
|
|
Study: Mechanomyography to Be Accurate in Detecting Nerves
Study: Researchers Find Mechanomyography to Be Accurate in Detecting Nerves During Minimally Invasive Spine Surgery DETROIT - An electronic device is an accurate technique for locating and avoiding nerves during spinal procedures, suggests a study by...
|
|
|
Novartis Receives EU Approval For Menveo
The European Commission (EC) has granted a marketing authorization for Novartis' Menveo (Meningococcal group A, C, W135 and Y conjugate vaccine) in all 27 European member states.Menveo is indicated for the active immunization of adolescents (from 11 years of...
|
|
|
Novartis' conjugate vaccine Menveo gets European marketing nod
Novartis announced that the European Commission (EC) granted a Marketing Authorization for Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine) in all 27 European member states.Menveo is indicated for the active immunization of adolescents (from...
|
|
|
Medical News: Carefusion Launches New Device To Help Treat Spinal Fractures
News Useful Links Video Library tweetmeme_source = 'mnt_neurology'; tweetmeme_service = 'bit.ly'; Main Category: Also Included In: ; Article Date: 18 Mar 2010 - 4:00 PDT printer friendly // ord = Number(ord) || Math.floor(Math.random() * 1E10); if(typeof(dcopt)...
|
|
|
Spinal Restoration Initiates Patient Enrollment For Phase III Study Of Company's Biostat(R) System
Spinal Restoration, Inc.announced that patient enrollment in the company's Phase III study of the Biostat System for the treatment of discogenic chronic low back pain is now underway. The study, which will be conducted at 15 U.S. clinical sites, is...
|
|
|
Medical News: Spinal Restoration Initiates Patient Enrollment For Phase III Study Of Company's Biostat(R) System
Spinal Restoration, Inc.announced that patient enrollment in the company's Phase III study of the Biostat System for the treatment of discogenic chronic low back pain is now underway. The study, which will be conducted at 15 U.S. Medical News: ...
|
|
|
Penn Researchers Clarify Cause of Spinal Muscular Atrophy
Gideon Dreyfuss, PhD, the Isaac Norris Professor of Biochemistry and Biophysics at the , and Investigator, Howard Hughes Medical Institute (HHMI), and Sungchan Cho, PhD, a postdoctoral researcher in the Dreyfuss lab, have made a surprising discovery regarding...
|
|
|
Medical News: Magellan Spine Technologies Announces Full Enrollment In The Spinal Disc Annular Repair Technology (DART) 20 Patient Initial Human Use Study
Magellan Spine Technologies, Inc.announced it had completed enrollment in a twenty patient study to evaluate the Magellan DART (Disc Annular Repair Technology) System for Annular Repair following lumbar discectomy procedures. This first study demonstrates...
|
|
|
Competitive bidding program for durable medical equipment: Myths and realities
Medicare has been touting the merits of the "competitive" bidding program for durable, or home medical equipment and services (HME) to convince Congress that the program is good for seniors.Unfortunately, proponents have conveyed misleading information and...
|
|
|
Magellan Spine Technologies Announces Full Enrollment In The Spinal Disc Annular Repair Technology (DART) 20 P
Magellan Spine Technologies, Inc.announced it had completed enrollment in a twenty patient study to evaluate the Magellan DART (Disc Annular Repair Technology) System for Annular Repair following lumbar discectomy procedures. This first study demonstrates...
|
|
|
Botox: Stepping in a New Direction
LAKE CHARLES, La., March 17 /PRNewswire/ -- Everyone has heard of Botox being used to reduce the appearance of fine lines and wrinkles, but now the muscle-immobilizing treatment is moving to the opposite end of the body to get patients back on their feet.
|
|
|
Disability-themed book benefits Cancer Society
UW-O junior self-publishes book of short stories and poems written by students across the country | Updated: Thursday, March 18, 2010 Tanya Kreuger, a junior at UW-Oshkosh with spina bifida has recently published a book titled Disabled Bodies, Able Minds, a...
|
|
|
Alphatec Spine Announces Stockholder Approval of Share Issuance Related to the Acquisition of Scient
(GLOBE NEWSWIRE) -- Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions...
|
|
|
Wide Prenatal Screening for Spine Condition Is Costly
THURSDAY, March 18 (HealthDay News) -- It would not be cost-effective to universally screen pregnant women for the neurodegenerative disorder spinal muscular atrophy (SMA) in their fetuses, but screening might make sense for women who have a family...
|
